Dietary salt intake worsens the Th17-dependent inflammatory profile of patients with cirrhosis
Authors:
- Amalia TzoumpaATAmalia Tzoumpa
- Beatriz Lozano-RuizBLBeatriz Lozano-Ruiz
- Yin HuangYHYin Huang
- Joanna PicóJPJoanna Picó
- Alba MoratallaAMAlba Moratalla
- María Teresa PomaresMPMaría Teresa Pomares
- Iván HerreraIHIván Herrera
- Juanjo LozanoJLJuanjo Lozano
- Cayetano MirallesCMCayetano Miralles
- Pablo BellotPBPablo Bellot
- Paula PiñeroPPPaula Piñero
Open Access
- 24 July 2025
- journal article
- Published by American Society for Clinical Investigation in JCI Insight
- Vol. 10 (17)
Abstract
Background & Aims Liver cirrhosis is characterized by chronic inflammation and fibrosis, with Th17 cells playing a crucial role in its progression. Recent evidence suggests that dietary salt influences immune diseases by modulating Th17 differentiation. This study assessed the impact of dietary salt on Th17-driven inflammation in patients with compensated cirrhosis and explored its effects on liver injury in mouse models. Methods A non-drug, open-label, non-randomized study involved 37 patients with compensated cirrhosis, who were given personalized guidelines to reduce salt intake over three months. Changes in Th17-driven inflammation and liver function markers were assessed at baseline and after salt restriction. In parallel, the impact of a high-salt diet on hepatic CD4+ T cells was analyzed in mouse models of acute liver injury and fibrosis. Results High salt intake was associated with Th17-mediated inflammation and correlated with markers of impaired liver function in these patients. Importantly, moderating salt intake through a personalized nutritional intervention was sufficient to reduce CD4+ T cell- mediated inflammation. Furthermore, analysis of RNA-seq data revealed enrichment of salt-induced Th17 gene signatures in both liver tissue and peripheral cells from patients with liver disease. Similarly, mice fed a high salt diet showed hepatic enrichment of Th17 cells and exacerbated liver fibrosis upon injury. Mechanistic studies revealed that high sodium conditions activated NF-κB and induced IL-6 production in hepatocytes, which may promote Th17 responses. Conclusion Dietary salt exacerbates Th17-driven inflammation and contributes to cirrhosis progression. Salt reduction may represent a viable therapeutic approach to manage inflammation in compensated cirrhosis.Keywords
Funding Information
- Instituto de Salud Carlos III (PI19/01554, PI22/01907)
- Generalitat Valenciana (CDEI-03/20-A)
- National Research Agency (AEI), Ministry of Science (CNS2023-145676)
- Generalitat Valenciana (GRISOLIAP/2021/083)
- La Caixa Foundation (LCF/BQ/DI21/11860047)
This publication has 46 references indexed in Scilit:
- Sodium perturbs mitochondrial respiration and induces dysfunctional TregsCell Metabolism, 2023
- PKM2-dependent metabolic skewing of hepatic Th17 cells regulates pathogenesis of non-alcoholic fatty liver diseaseCell Metabolism, 2021
- Guidelines for the use of flow cytometry and cell sorting in immunological studies (second edition)European Journal of Immunology, 2019
- Metabolic Inflammation-Associated IL-17A Causes Non-alcoholic Steatohepatitis and Hepatocellular CarcinomaCancer Cell, 2016
- Th17 Cell Pathway in Human Immunity: Lessons from Genetics and Therapeutic InterventionsImmunity, 2015
- Single-Cell Genomics Unveils Critical Regulators of Th17 Cell PathogenicityCell, 2015
- IRF4 Transcription Factor-Dependent CD11b+ Dendritic Cells in Human and Mouse Control Mucosal IL-17 Cytokine ResponsesImmunity, 2013
- Potentiation of Th17 cytokines in aging process contributes to the development of colitisCellular Immunology, 2011
- Implication of Th17 and Th1 Cells in Patients with Chronic Active Hepatitis BJournal of Clinical Immunology, 2009
- The interleukin-17 pathway is involved in human alcoholic liver disease # †Hepatology, 2009